Is Candel Therapeutics, Inc. (CADL) a Buy, Sell, or Hold?
Candel Therapeutics, Inc.
NASDAQ:CADL
$9.64 USD
-$0.23 (-2.33%)
- Volume
- 1.14M
- Average Volume
- 2.14M
- Market Capitalization
- $529.24M
- P/E Ratio
- -9.81
- Dividend Yield
- 0.00%
- Price Target
- $22.00
- Year High
- $11.36
- Year Low
- $4.35
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $28.05
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
23
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
4
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 32321
CADL Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CADL Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Sims Mark E. | officer: Chief Commercial Officer | 2026-07-06 | A-Award | 10.03 | 2026-07-08 |
| Sims Mark E. | 2026-07-06 | 0 | 2026-07-08 | ||
| Barone Francesca | officer: Chief Scientific Officer | 2026-06-29 | S-Sale | 10.0554 | 2026-07-01 |
| Tyagarajan Seshu | officer: Chief Technology Officer | 2026-06-29 | S-Sale | 10.0216 | 2026-07-01 |
| Manning Paul B | director | 2026-06-30 | A-Award | 10.3 | 2026-07-01 |
| PAPA JOSEPH C | director | 2026-06-30 | A-Award | 10.3 | 2026-07-01 |
| Loggia Nicoletta | director | 2026-06-30 | A-Award | 10.3 | 2026-07-01 |
| Radhakrishnan Maha | director | 2026-06-23 | A-Award | 9.08 | 2026-06-24 |
| Loggia Nicoletta | director | 2026-06-23 | A-Award | 9.08 | 2026-06-24 |
| PAPA JOSEPH C | director | 2026-06-23 | A-Award | 9.08 | 2026-06-24 |
| Benz Edward J. JR | director | 2026-06-23 | A-Award | 9.08 | 2026-06-24 |
| Martell Christopher | director | 2026-06-23 | A-Award | 9.08 | 2026-06-24 |
| Gaeta Renee | director | 2026-06-23 | A-Award | 9.08 | 2026-06-24 |
| Nabel Gary J. | director | 2026-06-23 | A-Award | 9.08 | 2026-06-24 |
| Nguyen Diem | director | 2026-06-23 | A-Award | 9.08 | 2026-06-24 |
| Manning Paul B | director | 2026-06-23 | A-Award | 9.08 | 2026-06-24 |
| Manning Paul B | director | 2026-03-31 | A-Award | 4.9 | 2026-04-02 |
| PAPA JOSEPH C | director | 2026-03-31 | A-Award | 4.9 | 2026-04-02 |
| Loggia Nicoletta | director | 2026-03-31 | A-Award | 4.9 | 2026-04-02 |
| Manning Paul B | director | 2026-02-23 | P-Purchase | 5.45 | 2026-02-26 |
| Tyagarajan Seshu | officer: Chief Technology Officer | 2026-01-26 | A-Award | 6.01 | 2026-01-28 |
| Nichols William Garrett | officer: Chief Medical Officer | 2026-01-26 | A-Award | 6.01 | 2026-01-28 |
| Schoch Charles | officer: Chief Financial Officer | 2026-01-26 | A-Award | 6.01 | 2026-01-28 |
| Tak Paul Peter | director, officer: Chief Executive Officer | 2026-01-26 | A-Award | 6.01 | 2026-01-28 |
| Barone Francesca | officer: Chief Scientific Officer | 2026-01-26 | A-Award | 6.01 | 2026-01-28 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-07-28 | M-Exempt | 1.29 | 2025-07-30 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-07-28 | S-Sale | 6.98 | 2025-07-30 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-07-28 | M-Exempt | 1.29 | 2025-07-30 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-06-30 | M-Exempt | 1.29 | 2025-07-02 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-06-30 | S-Sale | 5.04 | 2025-07-02 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-06-30 | M-Exempt | 1.29 | 2025-07-02 |
| Tyagarajan Seshu | officer: Chief Technology Officer | 2025-06-25 | A-Award | 4.67 | 2025-06-26 |
| Tak Paul Peter | director, officer: Chief Executive Officer | 2025-06-25 | A-Award | 4.67 | 2025-06-26 |
| Manning Paul B | director | 2025-06-25 | A-Award | 4.67 | 2025-06-26 |
| Martell Christopher | director | 2025-06-25 | A-Award | 4.67 | 2025-06-26 |
| Schoch Charles | officer: Chief Financial Officer | 2025-06-25 | A-Award | 4.67 | 2025-06-26 |
| Loggia Nicoletta | director | 2025-06-25 | A-Award | 4.67 | 2025-06-26 |
| Nabel Gary J. | director | 2025-06-25 | A-Award | 4.67 | 2025-06-26 |
| Barone Francesca | officer: Chief Scientific Officer | 2025-06-25 | A-Award | 4.67 | 2025-06-26 |
| PAPA JOSEPH C | director | 2025-06-25 | A-Award | 4.67 | 2025-06-26 |
| Schoch Charles | officer: Chief Financial Officer | 2025-06-20 | A-Award | 4.75 | 2025-06-24 |
| Benz Edward J. JR | director | 2025-06-17 | A-Award | 4.94 | 2025-06-18 |
| Gaeta Renee | director | 2025-06-17 | A-Award | 4.94 | 2025-06-18 |
| Loggia Nicoletta | director | 2025-06-17 | A-Award | 4.94 | 2025-06-18 |
| Manning Paul B | director | 2025-06-17 | A-Award | 4.94 | 2025-06-18 |
| Martell Christopher | director | 2025-06-17 | A-Award | 4.94 | 2025-06-18 |
| Nabel Gary J. | director | 2025-06-17 | A-Award | 4.94 | 2025-06-18 |
| Nguyen Diem | director | 2025-06-17 | A-Award | 4.94 | 2025-06-18 |
| PAPA JOSEPH C | director | 2025-06-17 | A-Award | 4.94 | 2025-06-18 |
| Radhakrishnan Maha | director | 2025-06-04 | A-Award | 5.6 | 2025-06-06 |
| Radhakrishnan Maha | 2025-06-04 | 0 | 2025-06-06 | ||
| Nichols William Garrett | officer: Chief Medical Officer | 2025-03-18 | M-Exempt | 3.75 | 2025-03-20 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-03-18 | M-Exempt | 1.29 | 2025-03-20 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-03-18 | M-Exempt | 3.75 | 2025-03-20 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-03-18 | S-Sale | 8.7606 | 2025-03-20 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-03-18 | M-Exempt | 1.29 | 2025-03-20 |
| Barone Francesca | officer: Chief Scientific Officer | 2025-03-18 | M-Exempt | 1.55 | 2025-03-20 |
| Barone Francesca | officer: Chief Scientific Officer | 2025-03-18 | S-Sale | 8.7623 | 2025-03-20 |
| Barone Francesca | officer: Chief Scientific Officer | 2025-03-18 | M-Exempt | 1.55 | 2025-03-20 |
| Tak Paul Peter | director, officer: Chief Executive Officer | 2025-03-18 | S-Sale | 8.7701 | 2025-03-20 |
| Tak Paul Peter | director, officer: Chief Executive Officer | 2025-03-19 | S-Sale | 9.0025 | 2025-03-20 |
| Tyagarajan Seshu | officer: Chief Technology Officer | 2025-03-17 | M-Exempt | 1.29 | 2025-03-20 |
| Tyagarajan Seshu | officer: Chief Technology Officer | 2025-03-17 | S-Sale | 8.8224 | 2025-03-19 |
| Tyagarajan Seshu | officer: Chief Technology Officer | 2025-03-17 | M-Exempt | 1.29 | 2025-03-19 |
| Schoch Charles | officer: See Remarks | 2025-03-17 | S-Sale | 8.8338 | 2025-03-19 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2025-02-21 | D-Return | 12.02 | 2025-02-25 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2025-02-21 | D-Return | 12.02 | 2025-02-25 |
| Schoch Charles | officer: See Remarks | 2025-02-12 | A-Award | 8.55 | 2025-02-14 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-02-12 | A-Award | 8.55 | 2025-02-14 |
| Tyagarajan Seshu | officer: Chief Technology Officer | 2025-02-12 | A-Award | 8.55 | 2025-02-14 |
| Tak Paul Peter | director, officer: Chief Executive Officer | 2025-02-12 | A-Award | 8.55 | 2025-02-14 |
| Barone Francesca | officer: Chief Scientific Officer | 2025-02-12 | A-Award | 8.55 | 2025-02-14 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2025-02-10 | D-Return | 8.61 | 2025-02-13 |
| Barone Francesca | officer: Chief Scientific Officer | 2025-01-15 | S-Sale | 7.225 | 2025-01-17 |
| Tyagarajan Seshu | officer: Chief Technology Officer | 2025-01-15 | S-Sale | 7.225 | 2025-01-17 |
| Schoch Charles | officer: See Remarks | 2025-01-15 | S-Sale | 7.225 | 2025-01-17 |
| Tak Paul Peter | director, officer: Chief Executive Officer | 2025-01-15 | S-Sale | 7.225 | 2025-01-17 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-01-15 | S-Sale | 7.225 | 2025-01-17 |
| Barone Francesca | officer: Chief Scientific Officer | 2025-01-08 | S-Sale | 8.2182 | 2025-01-10 |
| Schoch Charles | officer: See Remarks | 2025-01-08 | S-Sale | 8.2182 | 2025-01-10 |
| Tak Paul Peter | director, officer: Chief Executive Officer | 2025-01-08 | S-Sale | 8.2182 | 2025-01-10 |
| Tyagarajan Seshu | officer: Chief Technology Officer | 2025-01-08 | S-Sale | 8.2182 | 2025-01-10 |
| Nichols William Garrett | officer: Chief Medical Officer | 2025-01-08 | S-Sale | 8.2183 | 2025-01-10 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-26 | D-Return | 9.01 | 2024-12-30 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-26 | D-Return | 9.01 | 2024-12-30 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-27 | D-Return | 8.85 | 2024-12-30 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-27 | D-Return | 8.85 | 2024-12-30 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-20 | D-Return | 9 | 2024-12-26 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-20 | D-Return | 9 | 2024-12-26 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-23 | D-Return | 8.52 | 2024-12-26 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-23 | D-Return | 8.52 | 2024-12-26 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-24 | D-Return | 8.82 | 2024-12-26 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-24 | D-Return | 8.82 | 2024-12-26 |
| Manning Paul B | director | 2024-12-16 | P-Purchase | 6 | 2024-12-18 |
| Manning Paul B | director | 2024-12-16 | P-Purchase | 6 | 2024-12-18 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-11 | D-Return | 8.53 | 2024-12-13 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-11 | D-Return | 8.53 | 2024-12-13 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-12 | D-Return | 10.04 | 2024-12-13 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-12 | D-Return | 10.04 | 2024-12-13 |
| Aguilar-Cordova Estuardo | 10 percent owner | 2024-12-04 | D-Return | 4.46 | 2024-12-06 |